Dyskinesia, Drug-Induced
"Dyskinesia, Drug-Induced" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
Descriptor ID |
D004409
|
MeSH Number(s) |
C10.228.662.262.500 C10.720.312 C25.723.276.612 C25.723.705.200
|
Concept/Terms |
Dyskinesia, Drug-Induced- Dyskinesia, Drug-Induced
- Drug-Induced Dyskinesia
- Drug-Induced Dyskinesias
- Dyskinesia, Drug Induced
- Dyskinesias, Drug-Induced
Dyskinesia, Medication-Induced- Dyskinesia, Medication-Induced
- Dyskinesia, Medication Induced
- Dyskinesias, Medication-Induced
- Medication-Induced Dyskinesias
- Medication-Induced Dyskinesia
- Medication Induced Dyskinesia
|
Below are MeSH descriptors whose meaning is more general than "Dyskinesia, Drug-Induced".
Below are MeSH descriptors whose meaning is more specific than "Dyskinesia, Drug-Induced".
This graph shows the total number of publications written about "Dyskinesia, Drug-Induced" by people in UAMS Profiles by year, and whether "Dyskinesia, Drug-Induced" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2016 | 0 | 1 | 1 | 2014 | 0 | 1 | 1 | 1999 | 2 | 1 | 3 | 1997 | 2 | 0 | 2 | 1996 | 1 | 0 | 1 | 1995 | 2 | 2 | 4 | 1994 | 2 | 0 | 2 | 1993 | 1 | 0 | 1 | 1990 | 1 | 0 | 1 | 1989 | 2 | 0 | 2 | 1988 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Dyskinesia, Drug-Induced" by people in Profiles over the past ten years.
-
Dhall R, Kreitzman DL. Advances in levodopa therapy for Parkinson disease: Review of RYTARY (carbidopa and levodopa) clinical efficacy and safety. Neurology. 2016 Apr 05; 86(14 Suppl 1):S13-24.
-
Zhang L, Balan G, Barreiro G, Boscoe BP, Chenard LK, Cianfrogna J, Claffey MM, Chen L, Coffman KJ, Drozda SE, Dunetz JR, Fonseca KR, Galatsis P, Grimwood S, Lazzaro JT, Mancuso JY, Miller EL, Reese MR, Rogers BN, Sakurada I, Skaddan M, Smith DL, Stepan AF, Trapa P, Tuttle JB, Verhoest PR, Walker DP, Wright AS, Zaleska MM, Zasadny K, Shaffer CL. Discovery and preclinical characterization of 1-methyl-3-(4-methylpyridin-3-yl)-6-(pyridin-2-ylmethoxy)-1H-pyrazolo-[3,4-b]pyrazine (PF470): a highly potent, selective, and efficacious metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator. J Med Chem. 2014 Feb 13; 57(3):861-77.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|